Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1669)
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
280
Price
$200.90
Total Value
$56.25K
Shares Held After
21,032
% of Holdings
1.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
235
Price
$199.88
Total Value
$46.97K
Shares Held After
21,312
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
235
Price
$198.49
Total Value
$46.64K
Shares Held After
21,547
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
371
Price
$200.97
Total Value
$74.56K
Shares Held After
21,032
% of Holdings
1.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
140
Price
$199.82
Total Value
$27.98K
Shares Held After
21,403
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
239
Price
$198.85
Total Value
$47.53K
Shares Held After
21,543
% of Holdings
1.1%
Evolus, Inc. (EOLS)
Avelar Rui — See Remarks
Shares
3,119
Price
$4.75
Total Value
$14.82K
Shares Held After
427,423
% of Holdings
0.7%
Evolus, Inc. (EOLS)
MOATAZEDI DAVID — Director
Shares
13,669
Price
$4.75
Total Value
$64.93K
Shares Held After
604,700
% of Holdings
2.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
VIEMED HEALTHCARE, INC. (VMD)
Moore Michael — President
Shares
65,000
Price
$8.77
Total Value
$570.05K
Shares Held After
1,585,812
% of Holdings
3.9%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
VIEMED HEALTHCARE, INC. (VMD)
Moore Michael — President
Shares
40,232
Price
$9.21
Total Value
$370.54K
Shares Held After
1,650,812
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
608
Price
$4.78
Total Value
$2.91K
Shares Held After
537,116
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
774
Price
$4.79
Total Value
$3.70K
Shares Held After
184,858
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
380
Price
$4.79
Total Value
$1.82K
Shares Held After
152,379
% of Holdings
0.2%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
608
Price
$4.79
Total Value
$2.91K
Shares Held After
173,616
% of Holdings
0.3%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
684
Price
$4.79
Total Value
$3.27K
Shares Held After
261,238
% of Holdings
0.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,533
Price
$144.11
Total Value
$653.25K
Shares Held After
301,185
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,537
Price
$143.42
Total Value
$650.70K
Shares Held After
305,718
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,629
Price
$142.17
Total Value
$231.59K
Shares Held After
310,255
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
33
Price
$4.76
Total Value
$157.08
Shares Held After
92,386
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
4,486
Price
$4.77
Total Value
$21.41K
Shares Held After
3,302,839
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
1,183
Price
$4.79
Total Value
$5.67K
Shares Held After
271,910
% of Holdings
0.4%
HENRY SCHEIN INC (HSIC)
Popeck Thomas C — CEO, Henry Schein Products
Shares
1,355
Price
$72.79
Total Value
$98.63K
Shares Held After
86,182
% of Holdings
1.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
39,000
Price
$2.50
Total Value
$97.50K
Shares Held After
0
% of Holdings
100.0%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
124
Price
$53.24
Total Value
$6.60K
Shares Held After
73,320
% of Holdings
0.2%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
4,977
Price
$52.79
Total Value
$262.72K
Shares Held After
73,444
% of Holdings
6.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,939
Price
$51.78
Total Value
$100.41K
Shares Held After
78,421
% of Holdings
2.4%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
1,163
Price
$97.44
Total Value
$113.32K
Shares Held After
58,518
% of Holdings
1.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,964
Price
$67.00
Total Value
$801.59K
Shares Held After
33,421
% of Holdings
26.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%
Showing 1–50 of 1669 transactions (page 1 of 34)